TWD 19.7
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 49.47 Million TWD | 0.32% |
2022 | 56.37 Million TWD | -5.51% |
2021 | 59.66 Million TWD | 4.05% |
2020 | 57.34 Million TWD | 9.08% |
2019 | 52.56 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 15.23 Million TWD | 2.38% |
2024 Q1 | 14.87 Million TWD | 4.56% |
2023 Q4 | 14.22 Million TWD | 0.0% |
2023 FY | 56.55 Million TWD | 0.32% |
2023 Q3 | 14.22 Million TWD | 6.93% |
2023 Q2 | 13.3 Million TWD | 0.0% |
2023 Q1 | 13.3 Million TWD | -6.9% |
2022 Q4 | 14.29 Million TWD | 0.0% |
2022 FY | 56.37 Million TWD | -5.51% |
2022 Q3 | 14.29 Million TWD | 0.0% |
2021 FY | 59.66 Million TWD | 4.05% |
2020 FY | 57.34 Million TWD | 9.08% |
2019 FY | 52.56 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Bio Preventive Medicine Corp. | 1.08 Million TWD | -4467.959% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 58.743% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 46.997% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 82.997% |
NaviFUS Corp. | 11.82 Million TWD | -318.289% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 22.584% |
TaiRx, Inc. | 217.13 Million TWD | 77.216% |
Sinew Pharma Inc. | 186.25 Million TWD | 73.439% |
Lin BioScience, Inc. | 1.09 Billion TWD | 95.49% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -68.544% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -19.262% |
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -14936.778% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 61.251% |
AP Biosciences Inc | 32.25 Million TWD | -53.384% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 90.302% |
RBC Bioscience Corporation | 58.35 Million TWD | 15.226% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 92.317% |
EirGenix Inc. | 236.74 Million TWD | 79.103% |
Enimmune corporation | 220.1 Million TWD | 77.524% |
Lukas Biomedical Inc. | 177.45 Million TWD | 72.121% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -54867.778% |
3D Global Biotech Inc. | 5.27 Million TWD | -838.017% |
TaiMed Biologics Inc. | 225.23 Million TWD | 78.036% |
Mycenax Biotech Inc. | -375.19 Million TWD | 113.186% |
TCI GENE Inc. | 174.61 Million TWD | 71.669% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -7.492% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 95.619% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -19.259% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 34.786% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 70.823% |
Neith Corporation | 66.87 Million TWD | 26.022% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 86.167% |
VBI | 32.55 Million TWD | -51.961% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 66.351% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 80.741% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 28.665% |
CHO Pharma, Inc. | 268.99 Million TWD | 81.609% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 33.168% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -274738.889% |
Visgeneer Inc. | 67.48 Million TWD | 26.69% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 77.554% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 52.592% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 74.062% |
Sagittarius Life Science Corp | 135.85 Million TWD | 63.585% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 81.413% |
GlycoNex Incorporation | 995 Thousand TWD | -4871.96% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 97.327% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 84.41% |
PharmaEngine, Inc. | 441.78 Million TWD | 88.802% |
Intech Biopharm Corporation | -163.99 Million TWD | 130.166% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 74.524% |
BiOptic Inc. | 108.69 Million TWD | 54.485% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 80.883% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 83.561% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 41.067% |
OBI Pharma, Inc. | 2.01 Billion TWD | 97.546% |
Savior Lifetec Corporation | 223.36 Million TWD | 77.852% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1791.816% |
Level Biotechnology Inc. | 151.99 Million TWD | 67.452% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 96.574% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 64.376% |
Acepodia, Inc. | 452.56 Million TWD | 89.069% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 90.855% |